Acceder Registro /

María Asunción ESTEVE PASTOR

Buscador

Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9. Review. PubMed PMID: 26559964.
AÑO: 2016
Esteve-Pastor MA, Núñez-Gil IJ, Marín F. The search for optimal anticoagulation therapy in ACS: The gap between clinical trials and current clinical guidelines. Thromb Haemost. 2015 Nov;114(5):872-4. doi: 10.1160/TH15-06-0512. PubMed PMID: 26271308.
AÑO: 2015; IF: 4.385
Esteve-Pastor MA, Marín F, Bertomeu-Martinez V, Roldán-Rabadán I, Cequier-Fillat Á, Badimon L, Muñiz-García J, Valdés M, Anguita-Sánchez M; FANTASIIA Study Investigators. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores. Intern Med J. 2016 May;46(5):583-9. doi: 10.1111/imj.13048. PubMed PMID: 26929032.
AÑO: 2016; IF: 1.902
Esteve-Pastor MA, Hernández-Romero D, Valdés M, Marín F. New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor? Molecules. 2016 Feb 27;21(3):284. doi: 10.3390/molecules21030284. Review. PubMed PMID: 26927051.
AÑO: 2016; IF: 2.861
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27. English, Spanish. PubMed PMID: 28034682.
AÑO: 2017; IF: 5.166

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R